| P50 | author | Barbara Picconi | Q42663948 |
| | Veronica Ghiglieri | Q42883463 |
| | Alessandro Tozzi | Q55835005 |
| | Antonio de Iure | Q83356415 |
| P2093 | author name string | Michela Tantucci | |
| | Paolo Calabresi | |
| | Cinzia Costa | |
| | Massimiliano Di Filippo | |
| | Francesca Romana Fusco | |
| | Franco Borsini | |
| | Carmen Giampà | |
| P2860 | cites work | Looking for the role of cannabinoid receptor heteromers in striatal function | Q24658338 |
| | Adenosine A2A receptors and basal ganglia physiology | Q24669783 |
| | Role of adenosine A2A receptors in parkinsonian motor impairment and l-DOPA-induced motor complications | Q28247343 |
| | Localization of dopamine D2 receptors on cholinergic interneurons of the dorsal striatum and nucleus accumbens of the rat | Q28574366 |
| | Facilitated glutamatergic transmission in the striatum of D2 dopamine receptor-deficient mice | Q28590689 |
| | Differential contribution of dopamine D2S and D2L receptors in the modulation of glutamate and GABA transmission in the striatum | Q28592815 |
| | The molecular logic of endocannabinoid signalling | Q29615356 |
| | A gene expression atlas of the central nervous system based on bacterial artificial chromosomes | Q29617753 |
| | Ultrastructural localization of adenosine A2A receptors suggests multiple cellular sites for modulation of GABAergic neurons in rat striatum | Q30306766 |
| | Dichotomous dopaminergic control of striatal synaptic plasticity | Q30493521 |
| | Competitive regulation of synaptic Ca2+ influx by D2 dopamine and A2A adenosine receptors | Q30495714 |
| | Molecular cloning of the rat A2 adenosine receptor: selective co-expression with D2 dopamine receptors in rat striatum | Q30945230 |
| | Distribution, biochemistry and function of striatal adenosine A2A receptors | Q33740841 |
| | Endocannabinoid signaling in the brain | Q34125520 |
| | Dopaminergic control of corticostriatal long-term synaptic depression in medium spiny neurons is mediated by cholinergic interneurons. | Q34521936 |
| | Targeting adenosine A2A receptors in Parkinson's disease | Q34571644 |
| | Frequency-specific and D2 receptor-mediated inhibition of glutamate release by retrograde endocannabinoid signaling | Q34650334 |
| | Dopamine-dependent synaptic plasticity in striatum during in vivo development | Q34658296 |
| | Therapeutic potential of adenosine A(2A) receptor antagonists in Parkinson's disease | Q36057484 |
| | A convergent model for cognitive dysfunctions in Parkinson's disease: the critical dopamine-acetylcholine synaptic balance. | Q36628908 |
| | An update on adenosine A2A-dopamine D2 receptor interactions: implications for the function of G protein-coupled receptors | Q36713961 |
| | Dopamine-mediated regulation of corticostriatal synaptic plasticity. | Q36762821 |
| | Adenosine A(2A) receptors, dopamine D(2) receptors and their interactions in Parkinson's disease | Q36873486 |
| | Interaction of dopamine and adenosine receptor function in behavior: studies with dopamine-deficient mice | Q36992439 |
| | The endocannabinoid system in Parkinson's disease | Q37264881 |
| | Looking BAC at striatal signaling: cell-specific analysis in new transgenic mice. | Q37600135 |
| | ??? | Q64765331 |
| | Pramipexole in routine clinical practice: a prospective observational trial in Parkinson's disease | Q39389371 |
| | 2-n-Butyl-9-methyl-8-[1,2,3]triazol-2-yl-9H-purin-6-ylamine and analogues as A2A adenosine receptor antagonists. Design, synthesis, and pharmacological characterization | Q40357867 |
| | Adenosine-dopamine receptor-receptor interactions as an integrative mechanism in the basal ganglia | Q41624006 |
| | Dopamine activation of endogenous cannabinoid signaling in dorsal striatum | Q41646203 |
| | Behavioural role of dopamine D1 receptors in the reserpine-treated mouse | Q42204063 |
| | Pramipexole binding and activation of cloned and expressed dopamine D2, D3 and D4 receptors | Q42277766 |
| | Electrophysiology and pharmacology of striatal neuronal dysfunction induced by mitochondrial complex I inhibition | Q42439876 |
| | Long-term synaptic depression in the striatum: physiological and pharmacological characterization | Q42453585 |
| | Therapeutic doses of L-dopa reverse hypersensitivity of corticostriatal D2-dopamine receptors and glutamatergic overactivity in experimental parkinsonism. | Q42461972 |
| | Electrophysiology of dopamine-denervated striatal neurons. Implications for Parkinson's disease | Q42497576 |
| | Endocannabinoid-mediated rescue of striatal LTD and motor deficits in Parkinson's disease models | Q42508054 |
| | Muscarinic m1 and m2 receptor proteins in local circuit and projection neurons of the primate striatum: anatomical evidence for cholinergic modulation of glutamatergic prefronto-striatal pathways | Q43601269 |
| | Postsynaptic endocannabinoid release is critical to long-term depression in the striatum | Q43971441 |
| | Experimental parkinsonism alters endocannabinoid degradation: implications for striatal glutamatergic transmission. | Q44102387 |
| | Loss of bidirectional striatal synaptic plasticity in L-DOPA-induced dyskinesia | Q44383212 |
| | Increased adenosine A2A receptors in the brain of Parkinson's disease patients with dyskinesias | Q44807332 |
| | Effects of acute dopamine depletion on responsiveness to D1 and D2 receptor agonists in infant and weanling rat pups | Q45010626 |
| | D2 dopamine receptor-mediated modulation of voltage-dependent Na+ channels reduces autonomous activity in striatal cholinergic interneurons. | Q45153496 |
| | G-protein-coupled receptor modulation of striatal CaV1.3 L-type Ca2+ channels is dependent on a Shank-binding domain. | Q45249950 |
| | Striatal spiny neurons and cholinergic interneurons express differential ionotropic glutamatergic responses and vulnerability: implications for ischemia and Huntington's disease | Q45295971 |
| | D2 receptor stimulation, but not D1, restores striatal equilibrium in a rat model of Parkinsonism. | Q45980594 |
| | Dopamine and cognitive functioning in de novo subjects with Parkinson's disease: effects of pramipexole and pergolide on working memory. | Q46018645 |
| | Modulation of synaptic transmission and long-term potentiation: effects on paired pulse facilitation and EPSC variance in the CA1 region of the hippocampus | Q46152163 |
| | Decreased binding of the D3 dopamine receptor-preferring ligand [11C]-(+)-PHNO in drug-naive Parkinson's disease | Q46157390 |
| | Dopamine modulation of state-dependent endocannabinoid release and long-term depression in the striatum. | Q46279749 |
| | l-DOPA dosage is critically involved in dyskinesia via loss of synaptic depotentiation | Q46904268 |
| | Interaction of A2A adenosine and D2 dopamine receptors modulates corticostriatal glutamatergic transmission | Q46986845 |
| | Spontaneous activity of neostriatal cholinergic interneurons in vitro. | Q47904266 |
| | Overexpression of D2/D3 receptors increases efficacy of ropinirole in chronically 6-OHDA-lesioned Parkinsonian rats | Q48134493 |
| | F(ab) secondary antibodies: a general method for double immunolabeling with primary antisera from the same species. Efficiency control by chemiluminescence | Q48171343 |
| | Synaptic regulation of action potential timing in neostriatal cholinergic interneurons. | Q48380076 |
| | Physiological, morphological, and histochemical characterization of three classes of interneurons in rat neostriatum | Q51652804 |
| | ST 1535: a preferential A2A adenosine receptor antagonist. | Q51805588 |
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Parkinson's disease | Q11085 |
| | striatum | Q1319792 |
| P304 | page(s) | 1850-1862 | |
| P577 | publication date | 2011-02-01 | |
| P1433 | published in | Journal of Neuroscience | Q1709864 |
| P1476 | title | The distinct role of medium spiny neurons and cholinergic interneurons in the D₂/A₂A receptor interaction in the striatum: implications for Parkinson's disease | |
| P478 | volume | 31 | |